Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer
- 1 March 2020
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 30 (3) , 364-371
Abstract
Introduction Growing evidence in the literature supports the accuracy of sentinel lymph node (SLN) biopsy in early-stage cervical cancer. One-step nucleic acid amplification (OSNA) is a rapid assay able to detect cytokeratin 19-mRNA in SLNs, and it can be used for intra-operative detection of low-volume metastases. The aim of this study was to evaluate the rate of low-volume metastasis in SLNs detected by OSNA in patients with early-stage cervical cancer. Secondary aims were to define the sensitivity and the negative predictive value of SLN biopsy assessed with OSNA. Methods After IRB approval, consecutive patients who underwent surgery for International Federation of Gynecology and Obstetrics stage IA1 with lymph-vascular space involvement to IB1 between November 2017 and July 2019 and had SLN biopsy and pelvic lymphadenectomy were included. SLNs were detected with indocyanine-green cervical injection and sent intra-operatively for OSNA. Results Eighteen patients underwent SLN assessment with OSNA and systematic pelvic lymphadenectomy in the study period. Four (22.2%) patients had unilateral and 14 (77.8%) had bilateral mapping. OSNA detected micro-metastasis in 6/18 (33.3%) patients. All micro-metastases were detected in patients with bilateral SLN mapping. The sensitivity and negative predictive value of SLN in detecting lymph node metastasis with OSNA calculated per pelvic sidewall were 85.7% and 96.1%, respectively. The false negative rate in mapped sidewalls was 14.3%. Discussion This is the first series entirely processing SLNs for OSNA in early-stage cervical cancer. OSNA is able to intra-operatively detect low-volume metastases in SLNs. Further studies are necessary to confirm the accuracy of this technique and to assess survival implications of low-volume metastases detected by OSNA.Keywords
This publication has 36 references indexed in Scilit:
- Molecular investigation of lymph nodes in colon cancer patients using one‐step nucleic acid amplification (OSNA)Cancer, 2012
- Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancerGynecologic Oncology, 2012
- Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancerCancer, 2011
- One-step nucleic acid amplification—a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study groupVirchows Archiv, 2008
- Molecular Diagnosis of Sentinel Lymph Node Metastases in Cervical Cancer Using Squamous Cell Carcinoma AntigenClinical Cancer Research, 2008
- Sentinel lymph node biopsy improves staging in early cervical cancerGynecologic Oncology, 2007
- Topographic distribution of sentinel lymph nodes in patients with cervical cancerGynecologic Oncology, 2006
- Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancerInternational Journal of Gynecological Cancer, 2006
- Detection of pelvic lymph node micrometastasis in stage IA2–IB2 cervical cancer by immunohistochemical analysisGynecologic Oncology, 2004
- Molecular quantification and mapping of lymph-node micrometastases in cervical cancerThe Lancet, 2001